WS Data Solutions
Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Strong Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Sell
C
Lyra Therapeutics, Inc. Common Stock (LYRA)
Surgical & Medical Instruments & Apparatus
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
480 ARSENAL WAY
WATERTOWN, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/01/2020
Market Cap
17,746,882
Shares Outstanding
52,560,000
Weighted SO
52,563,127
Total Employees
N/A
Upcoming Earnings
08/13/2024
Beta
-0.0080
Last Div
0.0000
Range
0.253-6.79
Chg
0.0011
Avg Vol
1735904
Mkt Cap
17746882
Exch
NASDAQ
Country
US
Phone
617 393 4600
DCF Diff
5.6778
DCF
-1.6478
Div Yield
0.0000
P/S
9.7510
EV Multiple
-0.3042
P/FV
0.6151
Div Yield %
0.0000
P/E
-0.1879
PEG
-0.0066
Payout
0.0000
Current Ratio
3.6021
Quick Ratio
3.6021
Cash Ratio
1.6552
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
142.4859
CCC
-142.4859
Gross Margin
-5.9967
Op Margin
-41.0071
Pretax Margin
-55.6764
Net Margin
-55.7088
Eff Tax Rate
-0.0003
ROA
-1.0720
ROE
-1.4374
ROCE
-0.9911
NI/EBT
1.0006
EBT/EBIT
1.3577
EBIT/Rev
-41.0071
Debt Ratio
0.3885
D/E
1.1863
LT Debt/Cap
0.5118
Total Debt/Cap
0.5426
Int Coverage
-69.6203
CF/Debt
-2.0575
Equity Multi
3.0533
Rec Turnover
0.0000
Pay Turnover
2.5617
Inv Turnover
0.0000
FA Turnover
0.0786
Asset Turnover
0.0192
OCF/Share
-1.1550
FCF/Share
-1.2051
Cash/Share
1.0311
OCF/Sales
-41.5429
FCF/OCF
1.0433
CF Coverage
-2.0575
ST Coverage
-17.7109
CapEx Coverage
-23.0794
Div&CapEx Cov
-23.0794
P/BV
0.6151
P/B
0.6151
P/S
9.7510
P/E
-0.1879
P/FCF
-0.2250
P/OCF
-0.2520
P/CF
-0.2520
PEG
-0.0066
P/S
9.7510
EV Multiple
-0.3042
P/FV
0.6151
DPS
0.0000
Latest Headlines (EST)
No Headlines Found